"We have completed two-phase trials so far, in which about 100 people were included. The results of which have been quite substantial," Dr. Shirish Arya of Tata Hospital said.
Mumbai (Maharashtra) [India] June 16 (ANI/PRNewswire): MedAlliance has announced the award of its second CE Mark: SELUTION SLR™ 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of coronary arterial disease.